Vir Biotechnology's market cap is currently ―. The company's EPS TTM is $-4.586; its P/E ratio is -1.87; Vir Biotechnology is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.64M	$ 3.80M	$ 46.71M	$ -12.54M	$ 371.43M
Gross Profit	$ 2.60M	$ 3.80M	$ 44.80M	$ 15.79M	$ 349.18M
EBIT	$ -166.59M	$ -197.62M	$ -143.19M	$ -151.64M	$ 194.96M
EBITDA	-	$ -195.90M	$ -146.91M	$ -157.31M	$ 196.65M
Net Income Common Stockholders	$ -163.41M	$ -194.78M	$ -140.90M	$ -101.60M	$ 175.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.69B	$ 1.85B	$ 2.24B	$ 2.38B	$ 2.35B
Total Assets	$ 2.04B	$ 2.24B	$ 2.67B	$ 2.80B	$ 2.70B
Total Debt	$ 114.12M	$ 117.81M	$ 121.46M	$ 123.84M	$ 131.06M
Net Debt	$ -1.57B	$ -1.73B	$ -2.12B	$ -2.26B	$ -2.22B
Total Liabilities	$ 369.81M	$ 433.67M	$ 695.13M	$ 724.13M	$ 546.12M
Stockholders Equity	$ 1.68B	$ 1.81B	$ 1.97B	$ 2.08B	$ 2.15B
Cash Flow	-
Free Cash Flow	-	$ -398.72M	$ -132.65M	$ -15.60M	$ 98.91M
Operating Cash Flow	$ -155.83M	$ -389.27M	$ -125.78M	$ -15.60M	$ 117.90M
Investing Cash Flow	$ -58.95M	$ 230.31M	$ 98.08M	-	$ -662.61M
Financing Cash Flow	$ 277.00K	$ 3.18M	$ 2.34M	-	$ 1.99M

Currency in USD

Vir Biotechnology Earnings and Revenue History

Income Statement >

Vir Biotechnology Debt to Assets

Balance Sheet >

Vir Biotechnology Cash Flow

Cash Flow >

Vir Biotechnology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing